| Neutrophil gelatinase–associated lipocalin (NGAL) as a marker of kidney damage D Bolignano, V Donato, G Coppolino, S Campo, A Buemi, A Lacquaniti, ... American journal of kidney diseases 52 (3), 595-605, 2008 | 766 | 2008 |
| Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease D Bolignano, A Lacquaniti, G Coppolino, V Donato, S Campo, MR Fazio, ... Clinical Journal of the American Society of Nephrology 4 (2), 337-344, 2009 | 683 | 2009 |
| Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients D Bolignano, A Lacquaniti, G Coppolino, V Donato, MR Fazio, G Nicocia, ... Kidney and Blood Pressure Research 32 (2), 91-98, 2009 | 275 | 2009 |
| Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene D Bolignano, V Donato, A Lacquaniti, MR Fazio, C Bono, G Coppolino, ... Cancer letters 288 (1), 10-16, 2010 | 236 | 2010 |
| Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease D Bolignano, A Lacquaniti, G Coppolino, S Campo, A Arena, M Buemi Kidney and Blood Pressure Research 31 (4), 255-258, 2008 | 188 | 2008 |
| Three independent factors in morals J Dewey HITIT UNIVERSITESI ILAHIYAT FAKULTESI DERGISI-JOURNAL OF DIVINITY FACULTY OF …, 2016 | 162 | 2016 |
| Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure D Bolignano, G Basile, P Parisi, G Coppolino, G Nicocia, M Buemi Rejuvenation research 12 (1), 7-14, 2009 | 159 | 2009 |
| From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology D Bolignano, G Coppolino, A Lacquaniti, M Buemi European journal of clinical investigation 40 (3), 273-276, 2010 | 127 | 2010 |
| Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function D Bolignano, G Coppolino, A Lacquaniti, G Nicocia, M Buemi Kidney and Blood Pressure Research 31 (4), 274-279, 2008 | 122 | 2008 |
| “Normoalbuminuric” diabetic nephropathy: tubular damage and NGAL A Lacquaniti, V Donato, B Pintaudi, G Di Vieste, V Chirico, A Buemi, ... Acta Diabetologica 50, 935-942, 2013 | 119 | 2013 |
| Obestatin: an interesting but controversial gut hormone A Lacquaniti, V Donato, V Chirico, A Buemi, M Buemi Annals of Nutrition and Metabolism 59 (2-4), 193-199, 2011 | 97 | 2011 |
| Real-time monitoring of breath ammonia during haemodialysis: use of ion mobility spectrometry (IMS) and cavity ring-down spectroscopy (CRDS) techniques G Neri, A Lacquaniti, G Rizzo, N Donato, M Latino, M Buemi Nephrology Dialysis Transplantation 27 (7), 2945-2952, 2012 | 92 | 2012 |
| High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children T Arrigo, V Chirico, V Salpietro, C Munafo, V Ferrau, E Gitto, A Lacquaniti, ... European journal of endocrinology 168 (4), 631-638, 2013 | 84 | 2013 |
| Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients D Bolignano, G Coppolino, A Romeo, L De Paola, A Buemi, A Lacquaniti, ... Nephrology dialysis transplantation 24 (11), 3398-3403, 2009 | 75 | 2009 |
| Alterations of lipid metabolism in chronic nephropathies: mechanisms, diagnosis and treatment A Lacquaniti, D Bolignano, V Donato, C Bono, MR Fazio, M Buemi Kidney and Blood Pressure Research 33 (2), 100-110, 2010 | 71 | 2010 |
| Renal biopsy: Still a landmark for the nephrologist L Visconti, V Cernaro, CA Ricciardi, V Lacava, V Pellicanò, A Lacquaniti, ... World journal of nephrology 5 (4), 321, 2016 | 68 | 2016 |
| Malnutrition in the elderly patient on dialysis A Lacquaniti, D Bolignano, S Campo, C Perrone, V Donato, MR Fazio, ... Renal failure 31 (3), 239-245, 2009 | 66 | 2009 |
| Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease L Visconti, S Benvenga, A Lacquaniti, V Cernaro, A Bruzzese, G Conti, ... Journal of clinical & translational endocrinology 6, 8-14, 2016 | 64 | 2016 |
| Emerging markers of cachexia predict survival in cancer patients P Mondello, A Lacquaniti, S Mondello, D Bolignano, V Pitini, C Aloisi, ... BMC cancer 14, 1-10, 2014 | 63 | 2014 |
| Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein V Cernaro, A Lacquaniti, R Lupica, A Buemi, D Trimboli, G Giorgianni, ... Medicinal research reviews 34 (1), 77-105, 2014 | 62 | 2014 |
